Anastrozole Tablet, Film Coated
Product Images NDC 42291-085

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 42291-085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1mg (085 30 1mg)

Anastrozole Tablets, USP 1 mg film-coated tablets by AvKARE. The label indicates 30 tablets per package and includes NDC 42291-085-30. Instructions for dispensing with patient information leaflet and storage conditions are partially visible. The label states "Rx Only" and provides manufacturer details.*

FDA Label Image

085 90 1mg

Label for Anastrozole Tablets USP 1 mg by AvKARE, displaying the product name, strength, and dosage form as film-coated tablets. The label indicates a quantity of 90 tablets, prescription only, with usage and storage instructions, manufacturer details in Pulaski, TN, and the NDC number 42291-085-90.*

FDA Label Image

Anastrozole Structural Formula (Anastrozole Tablets Usp A078058 1)

Chemical structure of anastrozole showing a triazole ring attached to a benzene ring with two nitrile-substituted isopropyl groups.*

FDA Label Image

Fig1 (Anastrozole Tablets Usp A078058 2)

A line chart showing disease-free survival over time in months, comparing two randomized treatments, anastrozole and tamoxifen. The y-axis represents the proportion alive and disease-free, and the x-axis represents disease-free survival time in months.*

FDA Label Image

Figure 2 — (Anastrozole Tablets Usp A078058 3)

A line graph showing disease-free survival over time in months, comparing randomized treatments of anastrozole and tamoxifen. The vertical axis represents the proportion of patients alive and disease-free, while the horizontal axis shows disease-free survival in months up to about 90 months. Two lines represent anastrozole (dashed) and tamoxifen (solid), depicting their comparative effectiveness over time.*

FDA Label Image

Figure 3 (- Anastrozole Tablets Usp A078058 4)

A Kaplan-Meier survival curve chart comparing time to event (in months) between two randomized treatments: Anastrozole and Tamoxifen. The vertical axis shows the proportion event free, ranging from 0.50 to 1.00, and the horizontal axis shows time from 0 to 120 months. The chart includes the number of patients at risk at various time points below the graph. The Anastrozole group is represented by a solid line, and the Tamoxifen group by a dashed line.*

FDA Label Image

Figure 4 (- Anastrozole Tablets Usp A078058 5)

A Kaplan-Meier survival curve chart comparing the proportion of event-free patients over time (up to 120 months) between two treatments: Anastrozole and Tamoxifen. The chart includes a table below showing the number of patients at risk at various time points for each treatment group.*

FDA Label Image

Figure 5 (Kaplan-Meier Probability of Time to Disease Progression for All Randomized Patients (Intent-to-Treat) in Trial 0030)

A Kaplan-Meier survival curve chart depicting time to progression in months for randomized treatments with Anastrozole and Tamoxifen. The vertical axis shows the proportion of patients without progression, and the horizontal axis indicates time in months, comparing the two treatments over a span of up to 32 months.*

FDA Label Image

Figure 6 (Kaplan-Meier Probability of Time to Progression for All Randomized Patients (Intent-to-Treat) in Trial 0027)

A Kaplan-Meier survival curve comparing time to progression in months for two randomized treatments, Anastrozole and Tamoxifen. The vertical axis shows the proportion of patients not progressed, and the horizontal axis shows time in months, with patient numbers at risk listed below the graph.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.